NCT04049331 2026-04-22
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
Seattle Institute for Biomedical and Clinical Research
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT02577926 2025-06-10
Ruxo-BEAT
RWTH Aachen University
Phase 2 Active not recruiting
NCT05883683 2024-07-24
MSPM
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not yet recruiting
NCT05913141 2023-06-22
PDO/PDO-TIL/PDOTS for Drug Screen
Shanghai Zhongshan Hospital
Recruiting
NCT02032784 2020-07-16
Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding
AdventHealth
Phase 4 Terminated
NCT02538471 2019-12-09
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
Weill Medical College of Cornell University
Phase 2 Terminated
NCT04088110 2019-09-12
Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
Fuzhou General Hospital
Phase 2 Unknown
NCT01403610 2019-07-24
Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
NCT03910712 2019-04-10
Pyrotinib
Peking Union Medical College Hospital
Phase 2 Unknown
NCT00582660 2017-06-15
UAB0040
University of Alabama at Birmingham
Phase 2 Completed
NCT01893879 2017-05-18
PCTTPL
Stanford University
Phase NA Terminated